RxDoctor Payments Data

Matthew McCarthy

Psychiatry · Kenosha, WINPI 1306917570

Payments from drug & device makers

$2,120in general payments, 2019–2025

Across 109 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$370
  • Alkermes, Inc.$277
  • AbbVie$235
  • Axsome Therapeutics, Inc.$230
  • Teva Pharmaceuticals USA, Inc.$214
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$180
  • plus $613 from 12 others

What the payments were for

  • Food & beverage$2,10899%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,120 in reported general payments places this provider in the 85th percentile of 543 psychiatry providers in Wisconsin.

See all psychiatry providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate62$212,288
Abilify MaintenaAripiprazole30$81,536
Risperdal ConstaRisperidone Microspheres53$79,276
VraylarCariprazine Hcl48$66,037
LatudaLurasidone Hcl24$41,977
LybalviOlanzapine/Samidorphan Malate15$41,118
CaplytaLumateperone Tosylate15$28,254
Risperidone ErRisperidone Microspheres26$20,604
Aripiprazole96$15,973
Olanzapine187$14,253
Chlorpromazine Hcl13$8,886
Clozapine134$8,424
LexaproEscitalopram Oxalate14$6,934
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine187$6,909
Lamotrigine ErLamotrigine11$6,072

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$92$291,564115 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$99$81,53630 claims
AbbVieVraylar, Lexapro$235$72,97162 claims
Sunovion Pharmaceuticals Inc.Latuda$29$41,97724 claims
Alkermes, Inc.Lybalvi$277$41,11815 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$180$28,25415 claims
Lilly USA, LLCOlanzapine$17$14,253187 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$20$4,82112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 543 psychiatry providers in Wisconsin.

Other psychiatry in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →